← All quick references

ClearRounds Health · Cardiology · Quick Reference

Obstructive Sleep Apnea and Cardiology

PDF coming soon
Sleep, CKM & ComorbiditiesAllAvailableOne-page PDF

OSA relationship to HTN, AF, HF, pulmonary pressures, resistant symptoms, screening, and CPAP adherence issues.

Last reviewed

July 17, 2026

Sources / guidelines to verify

  • AHA Scientific Statement: OSA & Cardiovascular Disease
  • AASM screening recommendations (STOP-BANG)
Disclaimer: Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.

One-page reference

Clinically reviewed by the site owner. Still verify against the sources above and local protocol before clinical use.

1

What it is / why it matters

  • Repetitive upper-airway collapse → intermittent hypoxia and sympathetic surges.
  • Drives hypertension, AF, heart failure, and pulmonary hypertension — and undermines rhythm control.
2

Key diagnostic clues

  • Snoring, witnessed apneas, daytime sleepiness; obesity, large neck.
  • Resistant hypertension, nocturnal arrhythmia, refractory or post-ablation AF.
  • Screen with STOP-BANG (Snoring, Tiredness, Observed apnea, Pressure [HTN], BMI >35, Age >50, Neck >40 cm / 16 in, Gender male — score ≥3 = elevated risk) or Epworth.
3

Initial workup

  • Screen and refer for a sleep study (home or in-lab) when suspected.
  • Have a low threshold in resistant HTN, AF, HFpEF, and pulmonary hypertension.
4

Management framework

  • CPAP is first-line; weight loss and positional therapy help.
  • Hypoglossal nerve stimulation (Inspire) for CPAP-intolerant moderate-to-severe OSA — requires sleep endoscopy without complete concentric palatal collapse; best outcomes at lower BMI. Improves AHI and symptoms (STAR trial, ADHERE registry); dedicated cardiovascular outcome data still emerging.
  • When CPAP isn’t tolerated and Inspire isn’t an option, weight loss is central therapy: start with diet and lifestyle modification, and add GLP-1-based therapy when lifestyle alone is failing (tirzepatide is FDA-approved for moderate-to-severe OSA with obesity — SURMOUNT-OSA). Complements, not replaces, airway therapy.
  • Treat comorbidities; focus relentlessly on CPAP adherence (the usual point of failure).
5

Red flags / escalate now

  • Severe daytime somnolence (driving/occupational risk).
  • Overlap with heart failure or pulmonary hypertension, or marked nocturnal desaturation.
6

Follow-up / monitoring

  • CPAP adherence/efficacy; reassess BP and arrhythmia burden.
7

Clinic pearls

  • Think OSA in resistant HTN and recurrent AF (especially after ablation).
  • Untreated OSA undermines rhythm control — adherence is everything.

Related quick references

📄 Hypertension📄 Atrial Fibrillation / Atrial Flutter📄 HFpEF

Suggest an edit or request this reference

Spot something to improve, or want this one-pager prioritized? Send feedback to the ClearRounds Health team.

Share feedback →
ClearRounds Health · Cardiology — Obstructive Sleep Apnea and Cardiology Quick Reference · Last reviewed: July 17, 2026 · Educational reference only. Not a substitute for clinician judgment, local protocols, or current guideline review.